Financial Performance - Net sales for the three months ended February 28, 2026, were $154.807 million, an increase of 6.8% compared to $145.528 million for the same period in 2025[13] - Gross profit for the six months ended February 28, 2026, was $144.997 million, down 2.3% from $148.083 million in the prior year[13] - Operating profit decreased to $25.020 million for the three months ended February 28, 2026, compared to $30.820 million in the same period of 2025, reflecting a decline of 18.8%[13] - Net earnings for the three months ended February 28, 2026, were $16.308 million, a decrease of 22.5% from $20.901 million in the prior year[13] - Earnings per share (EPS) for the three months ended February 28, 2026, were $0.31, down from $0.38 in the same period of 2025, representing a decline of 18.4%[13] - Comprehensive income for the three months ended February 28, 2026, was $24.131 million, an increase from $16.074 million in the same period of 2025[15] - Net earnings for the six months ended February 28, 2026, were $35,439 thousand, a decrease of 16.2% compared to $42,624 thousand in the same period of 2025[21] - The company reported a net income of $21,723,000 for the fiscal year ending August 31, 2024[24] Assets and Liabilities - Total assets as of February 28, 2026, were $795.495 million, a decrease from $827.867 million as of August 31, 2025[18] - Cash and cash equivalents decreased to $98.719 million from $151.558 million as of August 31, 2025, indicating a decline of 34.9%[18] - Current liabilities remained relatively stable at $136.420 million compared to $137.102 million as of August 31, 2025[18] - Total liabilities as of February 28, 2026, were $387.960 million, a slight decrease from $394.173 million as of August 31, 2025[18] - Total shareholders' equity as of February 28, 2026, was $407,535 thousand, down from $433,694 thousand at the end of August 31, 2025[23] - The accumulated other comprehensive loss decreased to $100,928 thousand from $104,134 thousand, indicating a slight improvement in overall financial health[29] Cash Flow and Investments - Cash provided by operating activities increased to $29,027 thousand, up from $16,108 thousand year-over-year, reflecting improved operational efficiency[21] - Capital expenditures for the six months were $5,734 thousand, significantly lower than $11,517 thousand in the prior year, indicating a reduction in investment spending[21] - The company reported a net decrease in cash and cash equivalents of $52,839 thousand, compared to a decrease of $47,585 thousand in the previous year[21] - The company did not make any cash payments for business acquisitions during the six months ended February 28, 2026, compared to $27,196 thousand in the prior year[21] - Capital expenditures for the consolidated total in the three months ended February 28, 2026, were $3.057 million, a decrease of 46.0% from $5.660 million in the prior year[70] Segment Performance - For the three months ended February 28, 2026, the IT&S segment reported net sales of $148.685 million, a 5.4% increase from $140.716 million in the prior year[69] - The gross profit for the IT&S segment for the three months ended February 28, 2026, was $68.751 million, down from $71.505 million in the prior year, indicating a decrease of 3.9%[70] - The operating profit for the IT&S segment for the three months ended February 28, 2026, was $31.520 million, a decline of 18.5% from $38.736 million in the prior year[70] - The IT&S segment's operating profit margin for the three months ended February 28, 2026, was 21.2%, down from 27.1% in the prior year[70] Restructuring and Acquisitions - The company reported restructuring charges of $3.283 million for the three months ended February 28, 2026, with no such charges in the prior year[13] - The company recorded $3.3 million in restructuring costs in the second quarter of fiscal 2026 as part of a plan to align the IT&S segment with current market conditions[47] - The acquisition of DTA was completed for an initial purchase price of $26.7 million, with potential earn-out payments of up to €36.0 million based on financial performance[49] Debt and Financing - The Company has $187.5 million in long-term debt as of February 28, 2026, down from $190 million as of August 31, 2025, after accounting for current maturities[52] - The Company refinanced its senior credit facility in September 2022, establishing a $600 million facility with a $400 million revolving line of credit and a $200 million term loan, maturing in September 2027[53] - The Company was in compliance with all financial covenants under the credit facility as of February 28, 2026, including a net leverage ratio not exceeding 3.75 to 1.00[54] Shareholder Activities - The Company repurchased 1,655,307 shares for $65.9 million in the six months ended February 28, 2026, under a new share repurchase program authorized in October 2025[63] - The cash dividend declared was $0.04 per share, resulting in a total cash dividend of $1,000 for the period[23] - The Company has repurchased a total of 33,436,688 shares for $973.5 million since the inception of its initial share repurchase program in fiscal 2012[63] Tax and Compliance - The effective income tax rate for the Company was 26.3% for the three months ended February 28, 2026, compared to 24.5% for the same period in 2025[65] - The effective tax rate for the three months ended February 28, 2026, was 26.3%, an increase from 24.5% in the prior year, primarily due to year-to-date losses and deductions in jurisdictions without tax benefits[66]
Enerpac Tool(EPAC) - 2026 Q2 - Quarterly Report